All Pharma News
price-trendAsk Us
Tillotts and TVM Capital form Mage Biologics to develop oral antibody therapy

Tillotts and TVM Capital form Mage Biologics to develop oral antibody therapy
INDIAN PHARMA POST
21 Jul 2023
Share Share
Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada

Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada
ECONOMIC TIMES
07 Apr 2023
Share Share
Tillotts Standardizes on Veeva Commercial Cloud Applications

Tillotts Standardizes on Veeva Commercial Cloud Applications
PRNEWSWIRE
28 Sep 2022
Share Share
Tillotts Pharma: DIFICLIRTM is recommended for C. difficile infection

Tillotts Pharma: DIFICLIRTM is recommended for C. difficile infection
BUSINESSWIRE
07 Dec 2021
Share Share
Tillotts introduces Opticore for colonic targeting active molecules

Tillotts introduces Opticore for colonic targeting active molecules
PHARMABIZ
21 Nov 2016
Share Share
Recipharm, Tillotts Pharma enter long term supply agreement

Recipharm, Tillotts Pharma enter long term supply agreement
PHARMABIZ
01 Sep 2016
Share Share
Perrigo nabs US rights to AZ Crohn’s drug

Perrigo nabs US rights to AZ Crohn’s drug
RSC
08 Dec 2015
Share Share
AstraZeneca sells U.S. drug rights to Perrigo for $380 mln

AstraZeneca sells U.S. drug rights to Perrigo for $380 mln
Ben Hirschler REUTERS
24 Nov 2015
Share Share
AstraZeneca divests off gastro drug for $215 mn

AstraZeneca divests off gastro drug for $215 mn
BioSpectrum Bureau BIOSPECTRUM
14 Jul 2015
Share Share